Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Current Deferred Revenue (2016 - 2025)

Aspen Aerogels (ASPN) has disclosed Current Deferred Revenue for 13 consecutive years, with $624000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Current Deferred Revenue fell 79.84% year-over-year to $624000.0, compared with a TTM value of $624000.0 through Jun 2025, down 79.84%, and an annual FY2024 reading of $2.2 million, down 5.05% over the prior year.
  • Current Deferred Revenue was $624000.0 for Q2 2025 at Aspen Aerogels, down from $2.6 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $11.3 million in Q3 2021 and bottomed at $624000.0 in Q2 2025.
  • Average Current Deferred Revenue over 5 years is $3.4 million, with a median of $2.4 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue tumbled 88.6% in 2021, then soared 342.54% in 2022.
  • Year by year, Current Deferred Revenue stood at $1.3 million in 2021, then skyrocketed by 342.54% to $5.8 million in 2022, then plummeted by 60.38% to $2.3 million in 2023, then decreased by 5.05% to $2.2 million in 2024, then tumbled by 71.62% to $624000.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for ASPN at $624000.0 in Q2 2025, $2.6 million in Q1 2025, and $2.2 million in Q4 2024.